Yuan C#, Yu X#, Wang J #, Shu B#, Wang Xi , Huang C, Lv X, Peng Q, Qi, Jing Zhang W, Zheng Y, Wang S, Liang Q, Shi Q, Li T, Huang H, Mei Z, Zhang H, Xu H, Cui J, Wang H, Zhang H, Shi B, Sun P, Zhang H, Ma Z, Feng Y, Chen L, Zeng T, Tang D, Wang Y. Multi-modal molecular determinants of clinically relevant osteoporosis subtypes, Cell Discov. 2024 Mar 12;10(28).
Chen F#, Hou W#, Yu X#, Wu J, Li Z, Xu J, Deng Z, Chen G, Liu B, Yin X, Yu W, Zhang L, Xu G, Ji H, Liang C, Wang Z. CBX4 deletion promotes tumorigenesis under KrasG12D background by inducing genomic instability. Signal Transduct Target Ther. 2023 Sep 12;8(1):343. doi: 10.1038/s41392-023-01623-0. PMID: 37696812;
Yu X, Zhang J, Sun S, Zhou X, Zeng T, Chen L. Individual-specific edge-network analysis for disease prediction. Nucleic Acids Res. 2017 Nov 16;45(20):e170. doi: 10.1093/nar/gkx787. PMID: 28981699; PMCID: PMC5714249.
02/2025-01/2029
Noncommunicable Chronic Diseases-National Science and Technology Major Project, ¥2,425,000, 2024ZD0532203
Research on Novel Molecular Biomarkers for Early Warning of Osteoporotic Fractures in Type 2 Diabetes Mellitus
Role: Project leader